A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2300 participants.
Also called NCT07788989
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,300 participants
- Sponsor
- Registry
-
NCT07788989
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07788989. Non-randomized; no masking; primary purpose treatment. Start 2027-04-14 (anticipated); primary completion 2029-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter
- Acronym
- SPECTRA-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- VARIPULSE Catheter System (PVI)
- Intervention (Device)
- VARIPULSE Catheter System (PVI and PWI)
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct07788989- Content hash
4ea362099ed5bed4b0830e5cdd0034ce17a6f2512794c27b86114273a3f2d7dc